within Pharmacolibrary.Drugs.ATC.N;

model N02BG06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.36,
    Cl             = 0.5066666666666666,
    adminDuration  = 600,
    adminMass      = 0.03,
    adminCount     = 1,
    Vd             = 0.163,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.013633333333333332,
    Tlag           = 9.96
  );

  annotation(Documentation(
    info ="<html><body><p>Nefopam is a centrally-acting non-opioid analgesic used for the relief of moderate to severe pain. It is unrelated chemically to NSAIDs or opioids and acts by inhibiting the reuptake of serotonin, norepinephrine, and dopamine. Nefopam is used in some countries for acute and chronic pain management but is not approved in the United States.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics reported for healthy adult volunteers, single oral dose.</p><h4>References</h4><ol><li><p>Aymard, G, et al., &amp; Diquet, B (2003). Comparative pharmacokinetics and pharmacodynamics of intravenous and oral nefopam in healthy volunteers. <i>Pharmacology &amp; toxicology</i> 92(6) 279–286. DOI:<a href=&quot;https://doi.org/10.1034/j.1600-0773.2003.920605.x&quot;>10.1034/j.1600-0773.2003.920605.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/12787260/&quot;>https://pubmed.ncbi.nlm.nih.gov/12787260</a></p></li><li><p>Sanga, M, et al., &amp; Mittur, A (2016). Pharmacokinetics, metabolism, and excretion of nefopam, a dual reuptake inhibitor in healthy male volunteers. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 46(11) 1001–1016. DOI:<a href=&quot;https://doi.org/10.3109/00498254.2015.1136989&quot;>10.3109/00498254.2015.1136989</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26796604/&quot;>https://pubmed.ncbi.nlm.nih.gov/26796604</a></p></li><li><p>Yu, J, et al., &amp; Mittur, A (2016). Pharmacokinetics, distribution, metabolism, and excretion of the dual reuptake inhibitor [(14)C]-nefopam in rats. <i>Xenobiotica; the fate of foreign compounds in biological systems</i> 46(11) 1026–1048. DOI:<a href=&quot;https://doi.org/10.3109/00498254.2016.1145755&quot;>10.3109/00498254.2016.1145755</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26927982/&quot;>https://pubmed.ncbi.nlm.nih.gov/26927982</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N02BG06;
